We tested the detection capability of the SC-QDP for identifying rare kinase inhibitor insensitive cells by assaying single CD34+ cells obtained from patients with chronic myelogenous leukemia (CML). This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.